Until recently, Choi et al. reported that the KLHL14 gene is a novel tumor suppressor in regulating NF-κB signaling, and inactivation of KLHL14 leads partial and relative resistance to the Bruton tyrosine kinase (BTK) inhibitor ibrutinib [32]. This evidence concerns the gene KLHL14 and neoplasm.